Global Fluorinated Pharmaceutical Intermediates Market Research Report 2025

Publication ID:

PB501254761

Publication Date:

February 5, 2025

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Fluorinated Pharmaceutical Intermediates was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fluorinated Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorinated Pharmaceutical Intermediates.
The Fluorinated Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fluorinated Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluorinated Pharmaceutical Intermediates companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Patheon
BASF
Jubilant
Granules
Ganesh
Chemcon
Chemours
Zhejiang Yongtai Technology
Shenzhen Capchem Technology
Zhejiang Zhongxin Fluoride Materials
Jiangsu Feiyu Technology
Shanghai Sinofluoro
Shanghai Aqbiopharma
Hangzhou Fluoro Pharmaceutical
Zhejiang Dayang Biotech
Shandong Feiyuan Group
Segment by Type
Aromatic Fluoride
Aliphatic Fluoride
Segment by Application
Antiviral Drug
Anti-infectives Drug
Antirheumatic Drug
Antibacterial Drug
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fluorinated Pharmaceutical Intermediates company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Aromatic Fluoride
1.2.3 Aliphatic Fluoride
1.3 Market by Application
1.3.1 Global Fluorinated Pharmaceutical Intermediates Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Antiviral Drug
1.3.3 Anti-infectives Drug
1.3.4 Antirheumatic Drug
1.3.5 Antibacterial Drug
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fluorinated Pharmaceutical Intermediates Market Perspective (2020-2031)
2.2 Global Fluorinated Pharmaceutical Intermediates Growth Trends by Region
2.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Fluorinated Pharmaceutical Intermediates Historic Market Size by Region (2020-2025)
2.2.3 Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2026-2031)
2.3 Fluorinated Pharmaceutical Intermediates Market Dynamics
2.3.1 Fluorinated Pharmaceutical Intermediates Industry Trends
2.3.2 Fluorinated Pharmaceutical Intermediates Market Drivers
2.3.3 Fluorinated Pharmaceutical Intermediates Market Challenges
2.3.4 Fluorinated Pharmaceutical Intermediates Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue
3.1.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue (2020-2025)
3.1.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Players (2020-2025)
3.2 Global Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Fluorinated Pharmaceutical Intermediates Revenue
3.4 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio
3.4.1 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluorinated Pharmaceutical Intermediates Revenue in 2024
3.5 Global Key Players of Fluorinated Pharmaceutical Intermediates Head office and Area Served
3.6 Global Key Players of Fluorinated Pharmaceutical Intermediates, Product and Application
3.7 Global Key Players of Fluorinated Pharmaceutical Intermediates, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fluorinated Pharmaceutical Intermediates Breakdown Data by Type
4.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Type (2020-2025)
4.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2026-2031)
5 Fluorinated Pharmaceutical Intermediates Breakdown Data by Application
5.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Application (2020-2025)
5.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Fluorinated Pharmaceutical Intermediates Market Size (2020-2031)
6.2 North America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2020-2025)
6.4 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fluorinated Pharmaceutical Intermediates Market Size (2020-2031)
7.2 Europe Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2020-2025)
7.4 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size (2020-2031)
8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2020-2025)
8.4 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size (2020-2031)
9.2 Latin America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2020-2025)
9.4 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size (2020-2031)
10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2020-2025)
10.4 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Fluorinated Pharmaceutical Intermediates Introduction
11.1.4 Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Fluorinated Pharmaceutical Intermediates Introduction
11.2.4 Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Patheon
11.3.1 Patheon Company Details
11.3.2 Patheon Business Overview
11.3.3 Patheon Fluorinated Pharmaceutical Intermediates Introduction
11.3.4 Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.3.5 Patheon Recent Development
11.4 BASF
11.4.1 BASF Company Details
11.4.2 BASF Business Overview
11.4.3 BASF Fluorinated Pharmaceutical Intermediates Introduction
11.4.4 BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.4.5 BASF Recent Development
11.5 Jubilant
11.5.1 Jubilant Company Details
11.5.2 Jubilant Business Overview
11.5.3 Jubilant Fluorinated Pharmaceutical Intermediates Introduction
11.5.4 Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.5.5 Jubilant Recent Development
11.6 Granules
11.6.1 Granules Company Details
11.6.2 Granules Business Overview
11.6.3 Granules Fluorinated Pharmaceutical Intermediates Introduction
11.6.4 Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.6.5 Granules Recent Development
11.7 Ganesh
11.7.1 Ganesh Company Details
11.7.2 Ganesh Business Overview
11.7.3 Ganesh Fluorinated Pharmaceutical Intermediates Introduction
11.7.4 Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.7.5 Ganesh Recent Development
11.8 Chemcon
11.8.1 Chemcon Company Details
11.8.2 Chemcon Business Overview
11.8.3 Chemcon Fluorinated Pharmaceutical Intermediates Introduction
11.8.4 Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.8.5 Chemcon Recent Development
11.9 Chemours
11.9.1 Chemours Company Details
11.9.2 Chemours Business Overview
11.9.3 Chemours Fluorinated Pharmaceutical Intermediates Introduction
11.9.4 Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.9.5 Chemours Recent Development
11.10 Zhejiang Yongtai Technology
11.10.1 Zhejiang Yongtai Technology Company Details
11.10.2 Zhejiang Yongtai Technology Business Overview
11.10.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Introduction
11.10.4 Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.10.5 Zhejiang Yongtai Technology Recent Development
11.11 Shenzhen Capchem Technology
11.11.1 Shenzhen Capchem Technology Company Details
11.11.2 Shenzhen Capchem Technology Business Overview
11.11.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Introduction
11.11.4 Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.11.5 Shenzhen Capchem Technology Recent Development
11.12 Zhejiang Zhongxin Fluoride Materials
11.12.1 Zhejiang Zhongxin Fluoride Materials Company Details
11.12.2 Zhejiang Zhongxin Fluoride Materials Business Overview
11.12.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Introduction
11.12.4 Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.12.5 Zhejiang Zhongxin Fluoride Materials Recent Development
11.13 Jiangsu Feiyu Technology
11.13.1 Jiangsu Feiyu Technology Company Details
11.13.2 Jiangsu Feiyu Technology Business Overview
11.13.3 Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Introduction
11.13.4 Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.13.5 Jiangsu Feiyu Technology Recent Development
11.14 Shanghai Sinofluoro
11.14.1 Shanghai Sinofluoro Company Details
11.14.2 Shanghai Sinofluoro Business Overview
11.14.3 Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Introduction
11.14.4 Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.14.5 Shanghai Sinofluoro Recent Development
11.15 Shanghai Aqbiopharma
11.15.1 Shanghai Aqbiopharma Company Details
11.15.2 Shanghai Aqbiopharma Business Overview
11.15.3 Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Introduction
11.15.4 Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.15.5 Shanghai Aqbiopharma Recent Development
11.16 Hangzhou Fluoro Pharmaceutical
11.16.1 Hangzhou Fluoro Pharmaceutical Company Details
11.16.2 Hangzhou Fluoro Pharmaceutical Business Overview
11.16.3 Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Introduction
11.16.4 Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.16.5 Hangzhou Fluoro Pharmaceutical Recent Development
11.17 Zhejiang Dayang Biotech
11.17.1 Zhejiang Dayang Biotech Company Details
11.17.2 Zhejiang Dayang Biotech Business Overview
11.17.3 Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Introduction
11.17.4 Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.17.5 Zhejiang Dayang Biotech Recent Development
11.18 Shandong Feiyuan Group
11.18.1 Shandong Feiyuan Group Company Details
11.18.2 Shandong Feiyuan Group Business Overview
11.18.3 Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Introduction
11.18.4 Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2020-2025)
11.18.5 Shandong Feiyuan Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Lonza
Catalent
Patheon
BASF
Jubilant
Granules
Ganesh
Chemcon
Chemours
Zhejiang Yongtai Technology
Shenzhen Capchem Technology
Zhejiang Zhongxin Fluoride Materials
Jiangsu Feiyu Technology
Shanghai Sinofluoro
Shanghai Aqbiopharma
Hangzhou Fluoro Pharmaceutical
Zhejiang Dayang Biotech
Shandong Feiyuan Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂